Success story of targeted therapy in chronic myeloid leukemia: A population-based study of patients diagnosed in Sweden from 1973 to 2008 Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Molecular Targeted Therapy
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines

abstract

  • This large population-based study shows a major improvement in outcome of patients with CML up to 79 years of age diagnosed from 2001 to 2008, mainly caused by an increasing use of IM. The elderly still have poorer outcome, partly because of a limited use of IM.

publication date

  • June 20, 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3138632

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.34.7146

PubMed ID

  • 21576640

Additional Document Info

start page

  • 2514

end page

  • 20

volume

  • 29

number

  • 18